Physician profile
Tate E Kirk
NPI 1811396377
$1,434.84
in general payments reported to CMS, 2019-2025
8 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $8.93 · 2021: $415 · 2022: $641 · 2023: $36.59 · 2024: $97.54 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $608.70 | 2020-2022 | |
| Inari Medical, INC. | $275.23 | 2022 | |
| Medtronic, INC. | $181.65 | 2021-2025 | Concertotm |
| Siemens Medical Solutions USA, INC. | $117.48 | 2022 | |
| Imperative Care, INC | $102.88 | 2025 | Symphony Catheter |
| Boston Scientific Corporation | $77.76 | 2024 | Axios |
| Argon Medical Devices, INC. | $36.59 | 2023 | Ivcf, Cleaner |
| Bard Peripheral Vascular, INC. | $34.55 | 2021-2024 | Trek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tate Kirk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.